Vaccine development comes with a host of problems that slows down the progression of producing one. Aside from the economic and time-sensitive factors, vaccines come with alternative effects that need to be studied and approved by national organizations (FDA) for general use:

• Antibody-dependent-enhancement (ADE)
• Comorbidities
• Challenge studies